Analysis of chlorthalidone in whole blood by high-performance liquid chromatography. 1986

M J Rosenberg, and K K Lam, and T E Dorsey

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002752 Chlorthalidone A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic. Chlorphthalidolone,Phthalamudine,Chlortalidone,Hygroton,Oxodoline,Thalitone
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

M J Rosenberg, and K K Lam, and T E Dorsey
February 1999, Fa yi xue za zhi,
M J Rosenberg, and K K Lam, and T E Dorsey
October 1990, Journal of chromatography,
M J Rosenberg, and K K Lam, and T E Dorsey
December 1982, Journal of chromatography,
M J Rosenberg, and K K Lam, and T E Dorsey
December 1982, Journal of chromatography,
M J Rosenberg, and K K Lam, and T E Dorsey
November 1981, Journal of chromatography,
M J Rosenberg, and K K Lam, and T E Dorsey
July 1978, Clinical chemistry,
M J Rosenberg, and K K Lam, and T E Dorsey
October 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
M J Rosenberg, and K K Lam, and T E Dorsey
June 1982, Journal of chromatography,
M J Rosenberg, and K K Lam, and T E Dorsey
May 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Copied contents to your clipboard!